Epilepsy in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Cerebrovascular Diseases

Volumn 24, Issue 2-3, 2007, Pages 316-317

  Haan, Joost ^a,b   Lesnik Oberstein, Saskia A J ^a   Ferrari, Michel D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CARBAMAZEPINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE;

ADULT; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; BRAIN INFARCTION; CASE REPORT; CEREBRAL ARTERY DISEASE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FAMILY HISTORY; FEAR; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LEUKOENCEPHALOPATHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANIC; PEDIGREE; PRIORITY JOURNAL; TONIC CLONIC SEIZURE;

ADULT; CADASIL; EPILEPSY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PEDIGREE; RECEPTORS, NOTCH;

EID: 34548064560     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106518     Document Type: Article

References (12)

1. Lesnik Oberstein SAJ, Haan J: CADASIL. Panminerva Med 2004;46:265-276.
2. Dichgans M: CADASIL: a monogenic condition causing stroke and subcortical vascular dementia. Cerebrovasc Dis 2002; 13(suppl 2):37-41.
3. Van Den Boom R, Lesnik Oberstein SAJ, Ferrari MD, Haan J, Van Buchem MA: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages - 3rd-6th decades. Radiology 2003;229:683-690.
4. De Reuck J, Vanhee F, Van Maele G, Claeys I: Magnetic resonance imaging after seizures in patients with an ischemic stroke. Cerebrovasc Dis 2007;23:339-343.
5. Bentes C, Pimentel J, Ferro JM: Epileptic seizures following subcortical infarcts. Cerebrovasc Dis 2001;12:331-334.
6. Dichgans M, Mayer M, Uttner I, et al: The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-739.
7. Singhal S, Bevan S, Barrick T, Rich P, Markus HS: The influence of genetic and cardiovascular risk factors on the CADASL phenotype. Brain 2004;127:2031-2038.
8. Desmond DW, Moroney JT, Lynch T, et al: The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999;30:1230-1233.
9. Lagas PA, Juvonen V: Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Nord J Psychiatry 2001;55:41-42.
10. Flemming KD, Nguyen TT, Abu-Lebdeh HS, et al: Hyperhomocysteinemia in patients with CADASIL. Mayo Clin Proc 2001;76:1213-1218.
11. Dichgans M, Herzog J, Gasser T: NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology 2001;57:1714-1717.
12. Tuominen S, Juvonen V, Amberla K, et al: Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched patients with the same R133C Notch3 mutation. Stroke 2001;32:1767-1774.